GigiGoesGugu (Talk | contribs) |
|||
| Line 6: | Line 6: | ||
-In order to characterize both the sensing and the effector plasmid I innoculated Bacteria in liquid LB cultures over-night. | -In order to characterize both the sensing and the effector plasmid I innoculated Bacteria in liquid LB cultures over-night. | ||
<BR><BR> | <BR><BR> | ||
| - | |||
<font size = "4"> Nanoparticles</font> <BR> | <font size = "4"> Nanoparticles</font> <BR> | ||
| Line 13: | Line 12: | ||
-We Biotinylated the two new nanoparticles batches. | -We Biotinylated the two new nanoparticles batches. | ||
| - | + | <BR> | |
-End of the anti-strepta resistance check (sample mix, use of strepatavidin beads and microscopy) | -End of the anti-strepta resistance check (sample mix, use of strepatavidin beads and microscopy) | ||
Sensing-Effector
Innoculation of Bacteria with our constructs
-In order to characterize both the sensing and the effector plasmid I innoculated Bacteria in liquid LB cultures over-night.
Nanoparticles
Biotinylation
-We Biotinylated the two new nanoparticles batches.
-End of the anti-strepta resistance check (sample mix, use of strepatavidin beads and microscopy)
DSL Measurements
We did DLS measurements of the new biotinylated nanoparticles (before dialysis).
"
